查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1631209

美國組織診斷市場規模、佔有率、趨勢分析報告：按技術/產品、應用和細分市場預測，2025-2030 年

U.S. Tissue Diagnostics Market Size, Share & Trends Analysis Report By Technology & Product (IHC, Primary & Special Staining), By Application (Breast Cancer, NSCLC), And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

美國組織診斷市場的成長與趨勢

根據 Grand View Research, Inc. 的一份新報告，美國組織診斷市場規模預計到 2030 年將達到 44 億美元，2025 年至 2030 年期間的複合年成長率為 8.3%。促進市場成長的關鍵因素包括美國癌症患者數量的持續增加、器官移植和捐贈數量的增加、以及個人化醫療和伴同性診斷的接受度不斷提高。

由於美國癌症發生率的急劇成長，解剖病理學領域正在經歷模式轉移。此外，分子病理學與解剖病理學的穩定融合、癌症檢測新型切片檢查的快速採用以及數位技術的整合預計將共同對市場成長產生積極影響。

組織分析描述了傳統分子技術難以理解的重要資訊。目前，製藥公司正在迅速採用伴同性診斷測試來為其產品獲得第一線治療指定/核准。此外，組織診斷在精準醫療的發展中變得越來越重要，因為它可用於識別可能受益於標靶治療的患者群體。

此外，隨著螢光原位雜合反應(FISH)、免疫組織化學 (IHC)、螢光(IF)、比較基因組雜合反應和次世代定序(NGS) 等升級技術的採用，組織診斷領域正在逐步發展。主要企業正致力於識別新型生物標記和開發先進的癌症診斷檢測方法。此外，該公司正在實施生物標記病理學家培訓計劃，以增加對最新病理學解決方案的採用。

美國組織診斷市場報告重點

  • 基於技術和產品，免疫組織化學領域預計將在 2024 年以 27.74% 的最大收入佔有率引領市場。
  • 根據應用，乳癌領域將在 2024 年佔據市場最大收入佔有率，達到 50.45%。組織診斷在評估乳癌患者中起著重要作用。
  • 按最終用途分類，醫院部門佔據市場主導地位，2024 年的收入佔有率最大，為 37.82%。醫院和診所對組織診斷系統和服務的使用正在逐年增加。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第 3 章美國組織診斷市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 美國組織診斷市場分析工具
    • 產業分析 – 波特五力分析
    • PESTEL 分析

美國4 章。

  • 細分儀表板
  • 美國組織診斷市場：技術與產品變化分析
  • 美國組織診斷市場：技術與產品展望
  • 2018-2030 年市場規模、預測及趨勢分析
  • 免疫組織化學
    • 裝置
    • 耗材
  • 原位雜合反應
    • 裝置
    • 耗材
    • 軟體
  • 原發染色及特殊染色
    • H&E 染色
    • 特殊染色
  • 數位病理學和工作流程
    • 全幻燈片成像
    • 影像分析資訊學
    • 資訊管理系統儲存與通訊
  • 解剖病理學
    • 裝置
    • 耗材

美國5 章。

  • 細分儀表板
  • 美國組織診斷市場：應用趨勢分析
  • 美國組織診斷市場：應用展望
  • 2018-2030 年市場規模、預測及趨勢分析
  • 乳癌
  • 非小細胞肺癌
  • 攝護腺癌
  • 胃癌
  • 其他癌症

美國章。

  • 細分儀表板
  • 美國組織診斷市場：最終用途差異分析
  • 美國組織診斷市場前景（按最終用途分類）
  • 2018-2030 年市場規模、預測及趨勢分析
  • 醫院
  • 實驗室
  • 製藥協會
  • 執行長

第7章 競爭格局

  • 市場參與企業分類
  • 主要市場參與企業的近期趨勢及影響分析
  • 2024 年公司市場佔有率分析
  • 主要企業簡介
    • Merck KGaA
    • Thermo Fisher Scientific, Inc
    • F. Hoffmann-La Roche Ltd
    • Abbott Laboratories
    • Siemens Healthineers AG
    • Danaher
    • bioMerieux SA
    • QIAGEN
    • Becton, Dickinson &Company（BD）
    • Agilent Technologies, Inc
    • General Electric Company
    • BioGenex
    • Cell Signaling Technology, Inc
    • Bio SB
    • DiaGenic ASA
    • Sakura Finetek Japan Co., Ltd
    • Abcam plc
    • Enzo Life Sciences, Inc
    • VITRO SA（Master Diagnostica）
    • TissueGnostics GmbH
Product Code: GVR-4-68038-270-9

U.S. Tissue Diagnostics Market Growth & Trends:

The U.S. tissue diagnostics market size is estimated to reach USD 4.40 billion by 2030, registering a CAGR of 8.3% from 2025 to 2030, according to a new report by Grand View Research, Inc. Pivotal factors supplementing the market growth include continuous rise in the cases of cancer, growth in organ transplantation & donation, and increased acceptance toward personalized medicine & companion diagnostics in the U.S. Increase in the number of research activities targeted toward the development of novel tissue diagnostics solutions is also expected to drive the market.

The field of anatomic pathology has witnessed a paradigm shift, which can be attributed to the exponential growth in cancer incidence in the U.S., thereby expanding the clinical pathology industry. Also, steady convergence of molecular pathology with anatomic pathology, steep adoption of novel biopsies for cancer detection, and integration of digital technologies is expected to collaboratively make a positive impact on market growth.

Tissue analysis provides significant information, which is difficult to understand using conventional molecular techniques. Currently, companion diagnostic tests are rapidly being adopted by pharmaceutical companies for obtaining first-line therapy designations/approvals for their products. In addition, their use in the identification of patient cohorts, which are likely to benefit from targeted therapeutics, has increased the significance of tissue diagnostics in the development of precision medicine.

In addition, the field of tissue diagnostics has witnessed gradual evolution with the introduction of upgraded technologies, including Fluorescence In Situ Hybridization (FISH), Immunohistochemistry (IHC), Immunofluorescence (IF), comparative genomic hybridization, and Next-Generation Sequencing (NGS). Key players are focused on identifying novel biomarkers and developing assays for advanced cancer diagnosis. Furthermore, companies are conducting biomarker pathologist training programs to boost the adoption rate of modern pathological solutions.

U.S. Tissue Diagnostics Market Report Highlights:

  • Based on technology & product, the immunohistochemistry segment led the market with the largest revenue share of 27.74% in 2024.
  • Based on application, the breast cancer segment led the market with the largest revenue share of 50.45% in 2024. Tissue diagnostics play a vital role in assessing breast cancer in patients.
  • Based on end use, the hospitals segment led the market with the largest revenue share of 37.82% in 2024. The usage of tissue diagnostic systems and services in hospitals & clinics has increased over the years.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Technology & Product
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Regional Scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. U.S. Tissue Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Emerging solutions pertaining to digital tissue diagnostics
      • 3.2.1.2. Advancements in imaging techniques and increasing affordability of diagnostics
      • 3.2.1.3. Growth of personalized therapeutics and diagnostics
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Presence of non-value-based reimbursement policy and high costs associated with usage of tissue diagnosis
  • 3.3. U.S. Tissue Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. U.S. Tissue Diagnostics Market: Technology & Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Tissue Diagnostics Market: Technology & Product Movement Analysis
  • 4.3. U.S. Tissue Diagnostics Market by Technology & Product Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Immunohistochemistry
    • 4.5.1. Immunohistochemistry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Instruments
      • 4.5.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.5.2.2. Slide Staining Systems
        • 4.5.2.2.1. Slide Staining Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.5.2.3. Tissue Microarrays
        • 4.5.2.3.1. Immunohistochemistry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.5.2.4. Tissue Processing Systems
        • 4.5.2.4.1. Tissue Processing Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.5.2.5. Slide Scanners
        • 4.5.2.5.1. Slide Scanners Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.5.2.6. Other Products
        • 4.5.2.6.1. Other Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Consumables
      • 4.5.3.1. Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.5.3.2. Reagents
        • 4.5.3.2.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.5.3.3. Antibodies
        • 4.5.3.3.1. Antibodies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. In situ Hybridization
    • 4.6.1. In situ Hybridization Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.2. Instruments
      • 4.6.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.3. Consumables
      • 4.6.3.1. Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.4. Software
      • 4.6.4.1. Software Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Primary & Special Staining
    • 4.7.1. Primary & Special Staining Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.7.2. H&E Staining
      • 4.7.2.1. H&E Staining Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.7.3. Special Staining
      • 4.7.3.1. Special Staining Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Digital Pathology and Workflow
    • 4.8.1. Digital Pathology and Workflow Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.8.2. Whole Slide Imaging
      • 4.8.2.1. Whole Slide Imaging Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.8.3. Image Analysis Informatics
      • 4.8.3.1. Image Analysis Informatics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.8.4. Information Management System Storage & Communication
      • 4.8.4.1. Information Management System Storage & Communication Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.9. Anatomic Pathology
    • 4.9.1. Anatomic Pathology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.9.2. Instruments
      • 4.9.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.9.2.2. Microtomes & Cryostat Microtomes
        • 4.9.2.2.1. Microtomes & Cryostat Microtomes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.9.2.3. Tissue Processors
        • 4.9.2.3.1. Tissue Processors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.9.2.4. Automatic Strainers
        • 4.9.2.4.1. Automatic Strainers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.9.2.5. Other Products
        • 4.9.2.5.1. Other Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.9.3. Consumables
      • 4.9.3.1. Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.9.3.2. Reagents & Antibodies
        • 4.9.3.2.1. Reagents & Antibodies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.9.3.3. Probes & Kits
        • 4.9.3.3.1. Probes & Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.9.3.4. Others
        • 4.9.3.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Tissue Diagnostics Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Tissue Diagnostics Market: Application Movement Analysis
  • 5.3. U.S. Tissue Diagnostics Market by Application Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Breast Cancer
    • 5.5.1. Breast Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Non-Small Cell Lung Cancer
    • 5.6.1. Non-Small Cell Lung Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Prostate Cancer
    • 5.7.1. Prostate Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Gastric Cancer
    • 5.8.1. Gastric Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Other Cancers
    • 5.9.1. Other Cancers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. Tissue Diagnostics Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Tissue Diagnostics Market: End Use Movement Analysis
  • 6.3. U.S. Tissue Diagnostics Market by End Use Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Hospitals
    • 6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Research Laboratories
    • 6.6.1. Research Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Pharmaceutical Organizations
    • 6.7.1. Pharmaceutical Organizations Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. CRO
    • 6.8.1. CRO Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Market Participant Categorization
  • 7.2. Recent Developments & Impact Analysis by Key Market Participants
  • 7.3. Company Market Share Analysis, 2024
  • 7.4. Key Company Profiles
    • 7.4.1. Merck KGaA
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Thermo Fisher Scientific, Inc
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. F. Hoffmann-La Roche Ltd
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. Abbott Laboratories
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. Siemens Healthineers AG
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. Danaher
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. bioMerieux SA
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. QIAGEN
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. Becton, Dickinson & Company (BD)
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. Agilent Technologies, Inc
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Product benchmarking
      • 7.4.10.4. Strategic initiatives
    • 7.4.11. General Electric Company
      • 7.4.11.1. Company overview
      • 7.4.11.2. Financial performance
      • 7.4.11.3. Product benchmarking
      • 7.4.11.4. Strategic initiatives
    • 7.4.12. BioGenex
      • 7.4.12.1. Company overview
      • 7.4.12.2. Financial performance
      • 7.4.12.3. Product benchmarking
      • 7.4.12.4. Strategic initiatives
    • 7.4.13. Cell Signaling Technology, Inc
      • 7.4.13.1. Company overview
      • 7.4.13.2. Financial performance
      • 7.4.13.3. Product benchmarking
      • 7.4.13.4. Strategic initiatives
    • 7.4.14. Bio SB
      • 7.4.14.1. Company overview
      • 7.4.14.2. Financial performance
      • 7.4.14.3. Product benchmarking
      • 7.4.14.4. Strategic initiatives
    • 7.4.15. DiaGenic ASA
      • 7.4.15.1. Company overview
      • 7.4.15.2. Financial performance
      • 7.4.15.3. Product benchmarking
      • 7.4.15.4. Strategic initiatives
    • 7.4.16. Sakura Finetek Japan Co., Ltd
      • 7.4.16.1. Company overview
      • 7.4.16.2. Financial performance
      • 7.4.16.3. Product benchmarking
      • 7.4.16.4. Strategic initiatives
    • 7.4.17. Abcam plc
      • 7.4.17.1. Company overview
      • 7.4.17.2. Financial performance
      • 7.4.17.3. Product benchmarking
      • 7.4.17.4. Strategic initiatives
    • 7.4.18. Enzo Life Sciences, Inc
      • 7.4.18.1. Company overview
      • 7.4.18.2. Financial performance
      • 7.4.18.3. Product benchmarking
      • 7.4.18.4. Strategic initiatives
    • 7.4.19. VITRO SA (Master Diagnostica)
      • 7.4.19.1. Company overview
      • 7.4.19.2. Financial performance
      • 7.4.19.3. Product benchmarking
      • 7.4.19.4. Strategic initiatives
    • 7.4.20. TissueGnostics GmbH
      • 7.4.20.1. Company overview
      • 7.4.20.2. Financial performance
      • 7.4.20.3. Product benchmarking
      • 7.4.20.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 U.S. Tissue Diagnostics market, by Technology & Product, 2018 - 2030 (USD Million)
  • Table 4 U.S. Tissue Diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 5 U.S. Tissue Diagnostics market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information procurement
  • Fig. 2 Primary research pattern
  • Fig. 3 Market research approaches
  • Fig. 4 Value chain-based sizing & forecasting
  • Fig. 5 Market formulation & validation
  • Fig. 6 U.S. tissue diagnostics market segmentation
  • Fig. 7 Market driver analysis (current & future impact)
  • Fig. 8 Market restraint analysis (current & future impact)
  • Fig. 9 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 10 Porter's five forces analysis
  • Fig. 11 U.S. tissue diagnostics market, technology & product outlook key takeaways 2024 & 2030 (USD Million)
  • Fig. 12 U.S. tissue diagnostics market, application outlook key takeaways 2024 & 2030 (USD Million)
  • Fig. 13 U.S. tissue diagnostics market, end use outlook key takeaways 2024 & 2030 (USD Million)
  • Fig. 14 Immunohistochemistry market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Instruments market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 16 Slide Staining Systems market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 17 Tissue Microarrays market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Tissue Processing Systems market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Slide Scanners market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Other Products market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Consumables market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Reagents market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Antibodies market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Kits market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 In situ Hybridization market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Instruments market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Consumables market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Software market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Primary & Special Staining market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 H&E Staining market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Special Staining market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Digital Pathology and Workflow market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Whole Slide Imaging market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Image Analysis Informatics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Information Management System Storage & Communication market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Anatomic Pathology market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Instruments market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Microtomes &Cryostat Microtomes market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Tissue Processors market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Automatic Strainers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Other Products market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Consumables market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Reagents & Antibodies market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Probes & Kits market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Breast Cancer market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Non-Small Cell Lung Cancer market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Prostate Cancer market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Gastric Cancer market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Other Cancers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Hospital market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Research Laboratories market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Pharmaceutical Organizations market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 CRO market revenue estimates and forecasts, 2018 - 2030 (USD Million)